Literature DB >> 28795266

Whole-genome sequence analysis of Zika virus, amplified from urine of traveler from the Philippines.

Se Hun Gu1, Dong Hyun Song1, Daesang Lee1, Jeyoun Jang2, Min Young Kim2, Jaehun Jung3, Koung In Woo3, Mirang Kim3, Woong Seog3, Hong Sang Oh3, Byung Seop Choi3, Jong-Seong Ahn3, Quehn Park2, Seong Tae Jeong4.   

Abstract

Zika virus (ZIKV) (genus Flavivirus, family Flaviviridae) is an emerging pathogen associated with microcephaly and Guillain-Barré syndrome. The rapid spread of ZIKV disease in over 60 countries and the large numbers of travel-associated cases have caused worldwide concern. Thus, intensified surveillance of cases among immigrants and tourists from ZIKV-endemic areas is important for disease control and prevention. In this study, using Next Generation Sequencing, we reported the first whole-genome sequence of ZIKV strain AFMC-U, amplified from the urine of a traveler returning to Korea from the Philippines. Phylogenetic analysis showed geographic-specific clustering. Our results underscore the importance of examining urine in the diagnosis of ZIKV infection.

Entities:  

Keywords:  Next generation sequencing (NGS); Philippines; South Korea; Whole-genome sequence; Zika virus

Mesh:

Year:  2017        PMID: 28795266      PMCID: PMC5698360          DOI: 10.1007/s11262-017-1500-9

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


Zika virus (ZIKV), a single-stranded, positive-sense RNA virus belonging to the Flavivirus genus of the Flaviviridae family, is transmitted by mosquitoes of the Aedes species (Ae. aegypti and Ae. albopictus). ZIKV was first identified in a sentinel rhesus monkey in the Zika Forest in Uganda in 1947 [1-3]. Recently, ZIKV has become one of the most important mosquito-borne viruses, with outbreaks associated with microcephaly [4] and Guillain-Barré syndrome [5] in the Americas, Pacific, and Southeast Asia. As of January 2017, 17 ZIKV infection cases (13 male and 4 female) have been confirmed in Korea, according to the Korea Centers for Disease Control and Prevention (KCDC). All 17 cases have been related to travel to South America and Southeast Asia: one to Brazil (case #1) [6], seven to the Philippines (cases #2, 3, 5, 12, 13, 15, 17), four to Vietnam (cases #4, 9, 11, 16), one to the Dominican Republic (case #6), one to the Republic of Guatemala (case #7), one to Puerto Rico (case #8), and two to Thailand (cases #10, 14) (unpublished data from KCDC). Here, we report the full-length genome sequence of ZIKV strain AFMC-U, amplified from the urine of a male recruit (case #3) in a Korean Army training center in the Republic of Korea, using next generation sequencing technology. In April 10–14, 2016, two brothers, ages 20 and 21 years (cases #2 and #3), returned to Korea from Boracay, Philippines. The younger brother (case #2) was hospitalized with flu-like symptoms and rash, and ZIKV infection was diagnosed in a urine sample, using Zika Virus Polyprotein gene genesig® Standard Kit (Primerdesign Ltd, United Kingdom) (unpublished data from KCDC). Two weeks after returning, the older brother (case #3) joined the Korean Army, and although he was asymptomatic, serum, saliva and urine samples were collected. Total RNA was extracted from serum, saliva, and urine, using the QIAamp viral RNA mini kit (Qiagen, Hilden, Germany), and cDNA was prepared using the SuperScript III First-Strand Synthesis System (Invitrogen, San Diego, USA) and random hexamers. Oligo-nucleotide primer sequences for nested PCR were ZIKV-1F: 5′–AGTTGTTGATCTGTGTGAATCAGAC–3′ and ZIKV-637R: 5′–CATAGGGCATTCATAGCTCATGGT–3′, ZIKV-1F and ZIKV-397R: 5′–GCATTGATTATTCTCAGCATGGC–3′. Initial denaturation was 94 °C for 5 min, followed by 15 cycles of denaturation at 94 °C for 40 s, annealing at 50 °C for 40 s, elongation at 72 °C 1 min, then 25 cycles of denaturation at 94 °C for 40 s, annealing at 52 °C for 40 s and elongation at 72 °C for 1 min, in a. ProFlex™ PCR system (Applied Biosystems, Foster City, CA, USA). PCR products were purified by the QIAquick PCR purification Kit (Qiagen), and DNA sequencing was performed in both directions, using the Big-Dye terminator v3.1 cycle sequencing kit (Applied Biosystems) on an Applied Biosystems 3500 series Genetic Analyzer (Applied Biosystems). Both urine and saliva were positive, but serum was negative for ZIKV using RT-PCR. To obtain the whole-genome sequence of ZIKV from urine and saliva of case #3 by next generation sequencing (NGS) technology, a library was prepared using TruSeq RNA Access Library Prep Kit (Illumina, San Diego, CA, USA) according to manufacturer’s instruction. The library sizes and molar concentrations were determined by the Bio-analyzer with the Agilent DNA 1000 Kit (Agilent Technologies, Inc., Santa Clara, CA, USA), and the libraries were quantified using the Library Quantification kit for Illumina sequencing platforms (KAPA Biosystems, Wilmington, MA, USA) and a Quantstudio 6 Flex Real-time PCR (Applied Biosystems). Deep sequencing of ZIKV from urine and saliva of case #3 were performed on a MiSeq benchtop sequencer (Illumina) using a MiSeq reagent kit version 2 (Illumina) with 2  ×  150 bp paired-end, according to manufacturer’s instructions. The 5′- and 3′-terminal sequences were filled by designing specific primers, using the conventional Sanger sequencing method and SMARTer® RACE 5′/3′ Kit (Takara Bio Inc., Otsu, Japan). Total reads were qualified over Q20 score and trimmed for reference mapping (Reference sequence: NC_012532) and consensus sequences extraction using CLC Genomics Workbench version 7.5.2 (CLC Bio, Cambridge, MA, USA). Depth of coverage was calculated by the number of mapped reads (read length × number of reads matching to the reference/genome size of reference). NGS data from the urine sample (ZIKV strain AFMC-U) generated 1,012,451 reads (depth of coverage; 14,069.6) and saliva sample (ZIKV strain AFMC-S) generated 4791 reads (depth of coverage; 66.6) with a mean read length of 150 bases. We obtained the complete-genome and partial-genome sequence of ZIKV from urine and saliva sample, respectively. The full-length genome sequence of ZIKV strain AFMC-U was 10,795 nucleotides (GenBank accession no. KY553111) with 51.4% G+C content and 107-(1 to 107) and 428-nucleotide (10,368 to 10,795) 5′- and 3′-untranslated region (UTR), respectively. A 9063 nucleotide of ZIKV strain AFMC-S (GenBank accession no. KY962729) and ZIKV strain AFMC-U were identical (Table 1; Fig. 1). Whole-genome sequence comparison between ZIKV strain AFMC-U and ZIKV/H.sapiens-tc/PHL/2012/CPC-0740 from the Philippines (GenBank accession no. KU681082) showed 98.6 and 99.6% sequence similarity at the nucleotide and amino acid level, respectively (Table 1). Phylogenetic analysis, based on the nucleotide sequences, generated by the neighbor-joining method with 1000 bootstrap replicates using MEGA 6 [7]. The phylogenetic tree showed that ZIKV strain AFMC-U belonged to the Asian lineage and was closely related to a ZIKV strain from the Philippines (Fig. 1) [8, 9].
Table 1

Nucleotide and amino acid sequence similarity (%) between ZIKV strain AFMC-U and representative flaviviruses

VirusIsolate (strain)Genome (bp)Nucleotide (%)Amimo acid (%)
ZikaAFMC-S9063100.0100.0
ZikaH.sapiens-tc/PHL/2012/CPC-074010,80798.699.6
ZikaH.sapiens-tc/KHM/2010/FSS1302510,80797.999.4
ZikaH.sapiens-tc/THA/2014/SV0127-1410,80797.699.3
ZikaSZ01/2016/China10,27292.799.4
ZikaSZ-WIV0110,70996.799.4
ZikaGZ0110,27292.699.4
ZikaGD0110,57495.499.4
ZikaPLCal_ZV10,14191.799.4
ZikaTS17-201610,80697.799.4
ZikaH/PF/201310,80797.899.5
ZikaPRVABC-5910,80797.699.4
ZikaP6-74010,26990.799.4
ZikaSSABR110,64896.299.5
ZikaRio-U110,79597.599.4
ZikaMEX/InDRE/Sm/201610,61795.699.3
ZikaBrazil-ZKV201510,79397.599.4
ZikaBrazil/2016/INMI110,64396.299.4
ZikaHaiti/1225/201410,80797.699.4
ZikaZikaSPH201510,67696.499.3
ZikaZIKV/H.sapiens/Brazil/PE243/201510,80797.799.3
ZikaParaiba_0110,80797.799.4
ZikaNatal RGN10,80897.699.4
ZikaRio-S110,80597.699.4
ZikaArD12800010,27288.796.5
ZikaARB1356510,78888.797.3
ZikaArD15808410,27284.297.1
ZikaMR 76610,79489.096.6
ZikaMR766-NIID10,80789.096.6
ZikaMR 76610,76688.797.0
SpondweniSM-6 V-110,29065.174.8
West NileB95611,03856.556.9
Dengue 1Hawaii10,73657.455.4
Dengue 2D2/SG/CT38/201310,72057.655.4
Dengue 3H8710,69657.456.1
Dengue 4H24110,66457.555.8
Fig. 1

Phylogenetic analysis of the complete-genome sequences of Zika virus for a travel-associated case of Zika virus infection in a traveler returning to Korea from Boracay, Philippines, in April 2016. Phylogenetic tree was generated by the neighbor-joining method, using the Kimura 2-parameter model. Scale bar indicates number of base substitutions per site

Nucleotide and amino acid sequence similarity (%) between ZIKV strain AFMC-U and representative flaviviruses Phylogenetic analysis of the complete-genome sequences of Zika virus for a travel-associated case of Zika virus infection in a traveler returning to Korea from Boracay, Philippines, in April 2016. Phylogenetic tree was generated by the neighbor-joining method, using the Kimura 2-parameter model. Scale bar indicates number of base substitutions per site This is the first report of the whole-genome sequence from a travel-associated case of ZIKV infection in the Republic of Korea. Our results underscore the importance of examining urine for ZIKV RNA. Although no cases of autochthonous transmission of ZIKV have been found in Korea, the presence of Ae. albopictus mosquitoes in rural and urban areas of Korea should heighten awareness of this possibility among physicians, as well as public health and vector control personnel.
  9 in total

1.  Zika virus. I. Isolations and serological specificity.

Authors:  G W A DICK; S F KITCHEN; A J HADDOW
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

2.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.

Authors:  Koichiro Tamura; Glen Stecher; Daniel Peterson; Alan Filipski; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2013-10-16       Impact factor: 16.240

3.  Zika Virus Associated with Microcephaly.

Authors:  Jernej Mlakar; Misa Korva; Nataša Tul; Mara Popović; Mateja Poljšak-Prijatelj; Jerica Mraz; Marko Kolenc; Katarina Resman Rus; Tina Vesnaver Vipotnik; Vesna Fabjan Vodušek; Alenka Vizjak; Jože Pižem; Miroslav Petrovec; Tatjana Avšič Županc
Journal:  N Engl J Med       Date:  2016-02-10       Impact factor: 91.245

4.  Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013.

Authors:  E Oehler; L Watrin; P Larre; I Leparc-Goffart; S Lastere; F Valour; L Baudouin; Hp Mallet; D Musso; F Ghawche
Journal:  Euro Surveill       Date:  2014-03-06

5.  Complete Genome Sequences of Zika Virus Strains Isolated from the Blood of Patients in Thailand in 2014 and the Philippines in 2012.

Authors:  D W Ellison; J T Ladner; R Buathong; M T Alera; M R Wiley; L Hermann; W Rutvisuttinunt; C Klungthong; P Chinnawirotpisan; W Manasatienkij; M C Melendrez; I Maljkovic Berry; B Thaisomboonsuk; P Ong-Ajchaowlerd; W Kaneechit; J M Velasco; I A Tac-An; D Villa; C B Lago; V G Roque; T Plipat; A Nisalak; A Srikiatkhachorn; S Fernandez; I K Yoon; A D Haddow; G F Palacios; R G Jarman; L R Macareo
Journal:  Genome Announc       Date:  2016-05-12

6.  Complete Genome Sequences of Five Zika Virus Isolates.

Authors:  Jason T Ladner; Michael R Wiley; Karla Prieto; Chadwick Y Yasuda; Elyse Nagle; Matthew R Kasper; Daniel Reyes; Nikolaos Vasilakis; Vireak Heang; Scott C Weaver; Andrew Haddow; Robert B Tesh; Ly Sovann; Gustavo Palacios
Journal:  Genome Announc       Date:  2016-05-12

7.  Zika Virus in a Traveler Returning to China from Caracas, Venezuela, February 2016.

Authors:  Jiandong Li; Ying Xiong; Wei Wu; Xiaoqing Liu; Jing Qu; Xiang Zhao; Shuo Zhang; Jianhua Li; Weihong Li; Yong Liao; Tian Gong; Lijing Wang; Yong Shi; Yanfeng Xiong; Daxin Ni; Qun Li; Mifang Liang; Guoliang Hu; Dexin Li
Journal:  Emerg Infect Dis       Date:  2016-06-15       Impact factor: 6.883

8.  Isolation of Infective Zika Virus from Urine and Saliva of Patients in Brazil.

Authors:  Myrna C Bonaldo; Ieda P Ribeiro; Noemia S Lima; Alexandre A C Dos Santos; Lidiane S R Menezes; Stephanie O D da Cruz; Iasmim S de Mello; Nathália D Furtado; Elaine E de Moura; Luana Damasceno; Kely A B da Silva; Marcia G de Castro; Alexandra L Gerber; Luiz G P de Almeida; Ricardo Lourenço-de-Oliveira; Ana Tereza R Vasconcelos; Patrícia Brasil
Journal:  PLoS Negl Trop Dis       Date:  2016-06-24

9.  First Imported Case of Zika Virus Infection into Korea.

Authors:  Hee-Chang Jang; Wan Beom Park; Uh Jin Kim; June Young Chun; Su-Jin Choi; Pyoeng Gyun Choe; Sook-In Jung; Youngmee Jee; Nam-Joong Kim; Eun Hwa Choi; Myoung-Don Oh
Journal:  J Korean Med Sci       Date:  2016-05-27       Impact factor: 2.153

  9 in total
  6 in total

Review 1.  Advances in Diagnosis, Surveillance, and Monitoring of Zika Virus: An Update.

Authors:  Raj K Singh; Kuldeep Dhama; Kumaragurubaran Karthik; Ruchi Tiwari; Rekha Khandia; Ashok Munjal; Hafiz M N Iqbal; Yashpal S Malik; Rubén Bueno-Marí
Journal:  Front Microbiol       Date:  2018-01-19       Impact factor: 5.640

2.  Simple protocol for population (Sanger) sequencing for Zika virus genomic regions.

Authors:  Gabriela Bastos Cabral; João Leandro de Paula Ferreira; Renato Pereira de Souza; Mariana Sequetin Cunha; Adriana Luchs; Cristina Adelaide Figueiredo; Luís Fernando de Macedo Brígido
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-11-27       Impact factor: 2.743

3.  Re-visiting the evolution, dispersal and epidemiology of Zika virus in Asia.

Authors:  John H-O Pettersson; Jon Bohlin; Myrielle Dupont-Rouzeyrol; Ola B Brynildsrud; Kristian Alfsnes; Van-Mai Cao-Lormeau; Michael W Gaunt; Andrew K Falconar; Xavier de Lamballerie; Vegard Eldholm; Didier Musso; Ernest A Gould
Journal:  Emerg Microbes Infect       Date:  2018-05-09       Impact factor: 7.163

Review 4.  The Nuclear Pore Complex Is a Key Target of Viral Proteases to Promote Viral Replication.

Authors:  Luis Adrián De Jesús-González; Selvin Palacios-Rápalo; José Manuel Reyes-Ruiz; Juan Fidel Osuna-Ramos; Carlos Daniel Cordero-Rivera; Carlos Noé Farfan-Morales; Ana Lorena Gutiérrez-Escolano; Rosa María Del Ángel
Journal:  Viruses       Date:  2021-04-19       Impact factor: 5.048

5.  The Nuclear Pore Complex: A Target for NS3 Protease of Dengue and Zika Viruses.

Authors:  Luis Adrián De Jesús-González; Margot Cervantes-Salazar; José Manuel Reyes-Ruiz; Juan Fidel Osuna-Ramos; Carlos Noe Farfán-Morales; Selvin Noé Palacios-Rápalo; José Humberto Pérez-Olais; Carlos Daniel Cordero-Rivera; Arianna M Hurtado-Monzón; Fernando Ruíz-Jiménez; Ana Lorena Gutiérrez-Escolano; Rosa María Del Ángel
Journal:  Viruses       Date:  2020-05-26       Impact factor: 5.048

6.  The Ablation of Envelope Protein Glycosylation Enhances the Neurovirulence of ZIKV and Cell Apoptosis in Newborn Mice.

Authors:  Yanqing Guo; Linlin Bao; Yanfeng Xu; Fengdi Li; Qi Lv; Feiyue Fan; Chuan Qin
Journal:  J Immunol Res       Date:  2021-07-16       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.